Research into the biological differences and targets in lung cancer patients with diverse immunotherapy responses
BackgroundImmunotherapy has gradually become an important therapy option for lung cancer patients.MethodsThe Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases were responsible for all the public data.ResultsIn our study, we firstly identified 22 characteristic genes of NSCLC imm...
Main Authors: | Xunlang Zhang, Xinhui Wu, Huang Huang, Kangming Du, Yingying Nie, Peiyuan Su, Yuefei Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1014333/full |
Similar Items
-
Machine learning identifies characteristics molecules of cancer associated fibroblasts significantly correlated with the prognosis, immunotherapy response and immune microenvironment in lung adenocarcinoma
by: Qian Wang, et al.
Published: (2022-11-01) -
Integrative analysis illustrates the role of PCDH7 in lung cancer development, cisplatin resistance, and immunotherapy resistance: an underlying target
by: Huakang Li, et al.
Published: (2023-07-01) -
Immunotherapies to Nano-Immunotherapies: Advances in Immune Targeting in Bladder Cancer
by: Beatriz Ramos, et al.
Published: (2025-02-01) -
CD33 Expression on Peripheral Blood Monocytes Predicts Efficacy of Anti-PD-1 Immunotherapy Against Non-Small Cell Lung Cancer
by: Claire Olingy, et al.
Published: (2022-04-01) -
Research Advances on Small Molecule Targets for Tumor Immunotherapy
by: LIU Lie, et al.
Published: (2019-08-01)